Experimental Validation of a Fragment Library for Lead Discovery Using SPR Biosensor Technology

被引:25
作者
Elinder, Malin [1 ]
Geitmann, Matthis [2 ]
Gossas, Thomas [2 ]
Kallblad, Per [2 ]
Winquist, Johan [1 ]
Nordstrom, Helena [1 ]
Hamalainen, Markku [3 ]
Danielson, U. Helena [1 ,2 ]
机构
[1] Uppsala Univ, Dept Biochem & Organ Chem, SE-75123 Uppsala, Sweden
[2] Beactica AB, Uppsala, Sweden
[3] GE Healthcare Biosci AB, Uppsala, Sweden
关键词
SPR biosensor; fragment library; fragment screening; interaction analysis; enzyme; DRUG DISCOVERY; MOLECULAR COMPLEXITY; DESIGN; LEADLIKENESS; DATABASE;
D O I
10.1177/1087057110389038
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A new fragment library for lead discovery has been designed and experimentally validated for use in surface plasmon resonance (SPR) biosensor-based screening. The 930 compounds in the library were selected from 4.6 million commercially available compounds using a series of physicochemical and medicinal chemistry filters. They were screened against 3 prototypical drug targets: HIV-1 protease, thrombin and carbonic anhydrase, and a nontarget: human serum albumin. Compound solubility was not a problem under the conditions used for screening. The high sensitivity of the sensor surfaces allowed the detection of interactions for 35% to 97% of the fragments, depending on the target protein. None of the fragments was promiscuous (i.e., interacted with a stoichiometry >= 5: 1 with all 4 proteins), and only 2 compounds dissociated slowly from all 4 proteins. The use of several targets proved valuable since several compounds would have been disqualified from the library on the grounds of promiscuity if fewer target proteins had been used. The experimental procedure allowed an efficient evaluation and exploration of the new fragment library and confirmed that the new library is suitable for SPR biosensor-based screening. (Journal of Biomolecular Screening 2011:15-25)
引用
收藏
页码:15 / 25
页数:11
相关论文
共 30 条
[1]   Drug-like annotation and duplicate analysis of a 23-supplier chemical database totalling 2.7 million compounds [J].
Baurin, N ;
Baker, R ;
Richardson, C ;
Chen, I ;
Foloppe, N ;
Potter, A ;
Jordan, A ;
Roughley, S ;
Parratt, M ;
Greaney, P ;
Morley, D ;
Hubbard, RE .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2004, 44 (02) :643-651
[2]   Design and characterization of libraries of molecular fragments for use in NMR screening against protein targets [J].
Baurin, N ;
Aboul-Ela, F ;
Barril, X ;
Davis, B ;
Drysdale, M ;
Dymock, B ;
Finch, H ;
Fromont, C ;
Richardson, C ;
Simmonite, H ;
Hubbard, RE .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2004, 44 (06) :2157-2166
[3]   The properties of known drugs .1. Molecular frameworks [J].
Bemis, GW ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (15) :2887-2893
[4]  
BLOMBERG N, 2009, J COMPUT AIDED MOL D
[5]   Selection of heterocycles for drug design [J].
Broughton, HB ;
Watson, IA .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2004, 23 (01) :51-58
[6]   Characterization of Ca2+ and phosphocholine interactions with C-reactive protein using a surface plasmon resonance biosensor [J].
Christopeit, Tony ;
Gossas, Thomas ;
Danielson, U. Helena .
ANALYTICAL BIOCHEMISTRY, 2009, 391 (01) :39-44
[7]   A rule of three for fragment-based lead discovery? [J].
Congreve, M ;
Carr, R ;
Murray, C ;
Jhoti, H .
DRUG DISCOVERY TODAY, 2003, 8 (19) :876-877
[8]  
Danielson H, 1998, ADV EXP MED BIOL, V436, P99
[9]   Fragment Library Screening and Lead Characterization Using SPR Biosensors [J].
Danielson, U. Helena .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (18) :1725-1735
[10]   Determination of the refractive index increments of small molecules for correction of surface plasmon resonance data [J].
Davis, TM ;
Wilson, WD .
ANALYTICAL BIOCHEMISTRY, 2000, 284 (02) :348-353